about
Fludarabine treatment favors the retention of miR-485-3p by prostate cancer cells: implications for survivalIdentification of differentially expressed genes induced in the rat brain by acetyl-L-carnitine as evidenced by suppression subtractive hybridisation.Acetyl-L-carnitine up-regulates expression of voltage-dependent anion channel in the rat brain.Identification of differentially expressed genes induced by ozone stress in sensitive and tolerant poplar hybrids.Isolation and expression analysis of low temperature-induced genes in white poplar (Populus alba).MicroRNA (miRNA)-mediated interaction between leukemia/lymphoma-related factor (LRF) and alternative splicing factor/splicing factor 2 (ASF/SF2) affects mouse embryonic fibroblast senescence and apoptosisImmortalization of MEF is characterized by the deregulation of specific miRNAs with potential tumor suppressor activityA new method for discovering disease-specific MiRNA-target regulatory networksThe zebrafish/tumor xenograft angiogenesis assay as a tool for screening anti-angiogenic miRNAs.miR-20a and miR-290, multi-faceted players with a role in tumourigenesis and senescence.The RNA activator ds-p21 potentiates the cytotoxicity induced by fludarabine in Dohh2 cells.The Prostate Cancer Cells Resistant to Docetaxel as in vitro Model for Discovering MicroRNAs Predictive of the Onset of Docetaxel Resistance.Germline hereditary, somatic mutations and microRNAs targeting-SNPs in congenital heart defects.The over-expression of miR-34a fails to block DoHH2 lymphoma cell proliferation by reducing p53 via c-MYC down-regulation.Immortalized mouse embryo fibroblasts are resistant to miR-290-induced senescence regardless of p53 status.The Fuzzy Logic of MicroRNA Regulation: A Key to Control Cell ComplexityAlkaline Phosphatase-Positive Immortal Mouse Embryo Fibroblasts Are Cells in a Transitional Reprogramming State Induced to Face Environmental Stresses.Discovering the miR-26a-5p Targetome in Prostate Cancer Cells.The hunt for fatal myocardial infarction biomarkers: predictive circulating microRNAs.The miRNA Pull Out Assay as a Method to Validate the miR-28-5p Targets Identified in Other Tumor Contexts in Prostate Cancer.MiR-492 impairs the angiogenic potential of endothelial cells.miR-290 acts as a physiological effector of senescence in mouse embryo fibroblasts.Post-transcriptional Modulation of Sphingosine-1-Phosphate Receptor 1 by miR-19a Affects Cardiovascular Development in Zebrafish.Activation of the interferon type I response rather than autophagy contributes to myogenesis inhibition in congenital DM1 myoblastsIntegrative analysis of differentially expressed genes and miRNAs predicts complex T3-mediated protective circuits in a rat model of cardiac ischemia reperfusionmiR-29a and miR-30c negatively regulate DNMT 3a in cardiac ischemic tissues: implications for cardiac remodellingThe miR-28-5p Targetome Discovery Identified SREBF2 as One of the Mediators of the miR-28-5p Tumor Suppressor Activity in Prostate Cancer CellsEarly modifications of circulating microRNAs levels in metastatic colorectal cancer patients treated with regorafenibVariations of circulating miRNA in paediatric patients with Heart Failure supported with Ventricular Assist Device: a pilot studySystematic evaluation of the microRNAome through miR-CATCHv2.0 identifies positive and negative regulators of BRAF-X1 mRNA
P50
Q24294497-B80E5594-D216-41E7-8448-F2100C229841Q31129621-020C3C1B-DDA4-45EB-AA69-2B46AFB6DA97Q33235970-18E85AA1-507E-428D-B345-536095D92AF6Q33262548-6270FB4E-5D1E-4C1C-843A-E8ABC4055F44Q33451419-54684187-953C-4D62-99F3-10EAA06DB067Q34141907-A40A2178-48F7-4AD7-B3B7-26F2253E1C64Q34201222-AEEB3E2C-93A1-4692-9E80-E0F33929DCEBQ35302572-BF827F0F-D68A-495E-8F21-8325E7E9152CQ36237036-BE22B5BB-C814-4476-BE27-8262ECE489DFQ37813189-A108BBEB-591C-4B6C-8A6F-9F7F83544517Q38338012-376E61A3-0B6A-47D7-9AFB-F02BCF19F8F2Q38681199-9AB35F07-F467-4AC3-A077-3C9BB3F6432BQ39166944-FED7ECC3-371A-43C1-97BA-3AA4865E75BDQ39308517-971C1435-880F-42D7-99D6-EE2FFD3B962FQ39489455-A21E33CD-D7DD-457C-B3DC-122A26157EF6Q39969100-285B6821-0C88-4795-9D70-B65D8D0B2118Q40133831-8C08D016-C97F-418A-8503-44D48423949BQ41721802-D837DBF9-CEEE-449E-8F9F-EAF1F7193215Q42370342-BEBC6D5D-ED88-4A63-85B8-DC571A98CAD3Q42709133-B2FCA0CD-5DAC-4BC3-B1B3-BBA0EF638561Q42971453-3FA0731C-B8EA-48FB-BBC6-1AEE35C088D4Q43282335-8E99AD89-D132-4376-9519-C5291C455959Q55259963-71B35E5B-6F16-447B-95CA-9BF85EA02BBAQ57809704-2F991391-3F28-4CEF-97C4-018CE59C7318Q58740817-921A652F-A93D-4CB6-A4BF-2AEF50C5C394Q59711095-92A6D456-367A-4B16-87B6-019E9AF4A4EBQ89578588-F9233AD3-3896-4663-9E74-86E1C9A2C88EQ91241914-832C736B-2E58-4D26-8AE3-E6E7651AB6A9Q91555521-D4745D58-D840-4BFA-A5D6-CF8B609D5430Q92724796-DF60E7A6-219E-4F3E-ACF3-0968DF599B6D
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Milena Rizzo
@ast
Milena Rizzo
@en
Milena Rizzo
@es
Milena Rizzo
@nl
Milena Rizzo
@sl
type
label
Milena Rizzo
@ast
Milena Rizzo
@en
Milena Rizzo
@es
Milena Rizzo
@nl
Milena Rizzo
@sl
prefLabel
Milena Rizzo
@ast
Milena Rizzo
@en
Milena Rizzo
@es
Milena Rizzo
@nl
Milena Rizzo
@sl
P1053
L-1481-2016
P106
P21
P31
P3829
P496
0000-0001-5924-8615